Commentary: When to start and what to use in children--recommendations and rationale
AIDS
.
2014 Mar:28 Suppl 2:S133-5.
doi: 10.1097/QAD.0000000000000241.
Authors
George Siberry
1
,
Denis Tindyebwa
Affiliation
1
aMaternal and Pediatric Infectious Disease (MPID) Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA bANECCA, Kampala, Uganda.
PMID:
24849472
DOI:
10.1097/QAD.0000000000000241
No abstract available
Publication types
Comment
MeSH terms
Anti-Retroviral Agents / administration & dosage*
HIV Infections / drug therapy*
Humans
Infectious Disease Transmission, Vertical / prevention & control*
Substances
Anti-Retroviral Agents